Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

News | Cardiac Diagnostics

Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum ...

October 06, 2020

Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

News | Wearables

Flexible Electronics for Wearable Cardiac Monitoring Technologies

September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise ...

September 30, 2020

Videos | Coronavirus (COVID-19)

VIDEO: Overview of Multisystem Inflammatory Syndrome in Children (MIS-C) in COVID-19 Exposed Children

Deepika Thacker, M.D., a pediatric cardiologist with Nemours Children’s Health System, Wilmington, Del., helped discover ...

September 29, 2020

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Blog | ECG

BLOG: Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...

August 24, 2022

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE.

News | Wearables

VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the ...

September 25, 2020

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

News | Cardiac Imaging

Study Finds Removing Cost from Calcium Score Testing Increased Utilization

September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary artery ...

September 25, 2020

Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

News | Wearables

Fitbit ECG App to Identify Atrial Fibrillation Receives Regulatory Clearance in U.S. and Europe

September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as ...

September 24, 2020

Sponsored Content

Feature | ECG

Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler. “Plus, my patient compliance has increased. With the Holter, the leads sometimes come off. The patient may think the device isn’t working, so they take it off and we have to restart the process.”

February 19, 2020

Naples Community Hospital Director of Cardiac Imaging Bill Shirkey showing a point-of-care echocardiogram of a COVID-19 patient he imaged with a GE Healthcare Vscan device bedside in an isolation room. Use of a small handheld device greatly speeds disinfection after the exam and does not require moving a larger cart-based ultrasound system into a room, which may require moving furniture and add exposure time in the room.

Feature | Coronavirus (COVID-19)

Handheld Ultrasound Helps to Monitor COVID-19 Patients With Cardiac Conditions

September 15, 2020 — The world is facing a global pandemic with unknown implications, but is now well known COVID-19 ...

September 15, 2020

Exantham on abdomen and back of a pediatric patient at Nemours Children’s Health System in Delaware who presented with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the United States.

News | Coronavirus (COVID-19)

Case Study Describes One of the First U.S. Cases of MIS-C

September 14, 2020 – At the height of the COVID-19 (SAR-CoV-2) pandemic in April, a 14-year-old boy was admitted to the ...

September 14, 2020

Examples of pulmonary embolism clots caused by COVID-19 seen on a chest CT. From the journal Radiology

News | Coronavirus (COVID-19)

Possible Blood Clotting Mechanism in COVID-19 Found

September 3, 2020 — Why so many COVID-19 (SARS-CoV-2) patients get blood clots (thrombosis) remains uncertain. But ...

September 03, 2020

Sponsored Content

Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.

Feature | Sudden Cardiac Arrest

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease

Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent worldwide. Most professional athletes in the United States are required to take part in comprehensive cardiovascular screening programs to identify often-asymptomatic congenital or inherited heart disorders, and other cardiac risk factors. There remains a debate however, whether to mandate ECGs as part of pre-participation screening programs for student athletes at the collegiate and high school levels or even at younger ages.

October 16, 2018